Elevated neutrophil-to-lymphocyte ratio combined with decreased lymphocyte-to-monocyte ratio is associated with increased peripheral airway resistance in patients with hepatic steatosis.

Although the link between hepatic steatosis and lung function has been confirmed, the focus has largely been on central airways. The association between hepatic steatosis and increased peripheral airway resistance has not yet been explored. Hepatic steatosis and increased peripheral resistance are connected with immunity dysregulation. High neutrophil-to-lymphocyte ratio (NLR) and low lymphocyte-to-monocyte ratio (LMR) have been recognized as indicators of immunity dysregulation. In this study, the association between hepatic steatosis and increased peripheral airway resistance was evaluated, and the effect of immunity dysregulation (high NLR/low LMR) on the increased peripheral airway resistance among patients with hepatic steatosis was explored. In this retrospective study, chest or abdomen CT scans and spirometry/impulse oscillometry (IOS) from 2018 to 2019 were used to identify hepatic steatosis and increased central/peripheral airway resistance in patients. Among 1391 enrolled patients, 169 (12.1%) had hepatic steatosis. After 1:1 age and abnormal ALT matching was conducted, clinical data were compared between patients with and without hepatic steatosis. A higher proportion of patients with hepatic steatosis had increased peripheral airway resistance than those without hepatic steatosis (52.7% vs 40.2%, P = .025). Old age, high body mass index, history of diabetes, and high NLR/low LMR were significantly correlated with increased peripheral airway resistance. The presence of hepatic steatosis is associated with increased peripheral airway. High NLR/low LMR is an independent associated factor of increased peripheral airway resistance in patients with hepatic steatosis. It is advisable for patients with hepatic steatosis to regularly monitor their complete blood count/differential count and undergo pulmonary function tests including IOS.

A field pilot-scale study on heavy metal-contaminated soil washing by using an environmentally friendly agent-poly-γ-glutamic acid (γ-PGA).

In this study, a farmland contaminated by heavy metals (Cu, Zn, Ni, and Cr) was selected to evaluate the performance of poly-γ-glutamic acid (γ-PGA) on the removal of heavy metals in soil washing. The highest heavy metal concentrations at the contaminated site were Cu: 1180 mg/kg, Zn: 1450 mg/kg, Ni: 287 mg/kg, and Cr: 316 mg/kg. Batch experiments designed by Taguchi Method were conducted first to assess the effect of different washing conditions on the removal of heavy metals in laboratory. The results of batch experiments show that factors that affected the removal efficiency of heavy metals was of the order γ-PGA concentration > washing time > liquid/soil ratio > rotational speed. The optimal operating parameters for heavy metal removal were γ-PGA 3.5%, liquid/soil ratio 15/1, washing time 60 min, and rotational speed 100 rpm. Under the optimal conditions, up to 50.7% of the major target metal, Cu, was removed. Heavy metals in the soil were mainly Fe-Mn oxide bound and organically bound. On-site treatment using the optimal operating parameters caused 54.3% of Cu removal. When the soil was washed 3 times by γ-PGA, the removal efficiency of Cu was improved to 74.3%. After the treatment, the change in soil bacterial number was insignificant, indicating that γ-PGA is an environmentally friendly washing reagent.

Radiation doses with various body weights of phantoms in brain 128-slice MDCT examination.

The effective dose (HE) and organ or tissue equivalent dose (HT) for use in brain computed tomography (CT) examinations with various body weights were evaluated. Thermoluminescent dosimeters (TLD-100H) were inserted into Rando and five anthropomorphic phantoms. These phantoms were made of polymethylmethacrylate (PMMA), according to the specifications of ICRU 48, with masses from 10 to 90 kg. Brain CT examinations were conducted, scanning the maxillae from the external auditory meatus to the parietal bone using a 128-slice multi-detector CT (MDCT) scanner. To reduce errors, three independent trials were conducted. Calculated HE,TLD, based on the weighting factor recommended by ICRP 103, was 1.72 ± 0.28 mSv, which slightly exceeds the HE,DLP of 1.70 mSv, that was calculated from the dose-length product (DLP) of the Rando phantom. This experiment yielded HE,TLD values of ICRP 103 from the highest 1.85 ± 0.28 (90 kg) to the lowest 1.47 ± 0.22 (10 kg) mSv. HE,TLD (mSv) = 5.45×10-3 W(kg) + 1.361, with an R2 of 0.87667. Using the DLP protocol, HE,DLP was estimated from CTDIvol that was recorded directly from the console display of the CT unit and multiplied by the conversion coefficient (k) recommended by the ICRP 103. Finally, the experimental results obtained herein are compared with those in the literature. Physicians should choose and adjust protocols to prevent the exposure of patients to unnecessary radiation, satisfying the as low as reasonably achievable (ALARA) principle. These findings will be valuable to patients, physicians, radiologists and the public.